Search clinical trials for: EGFR-mutant
Total 30 results
-
Therapex Co., LtdNot yet recruitingCarcinoma, Non-Small-Cell Lung | EGFR Mutant Advanced Non-Small Cell Lung Cancer
-
The First Affiliated Hospital of Guangzhou Medical...Recruiting
-
Bridge Biotherapeutics, Inc.RecruitingEGFR Mutant Advanced Non-Small Cell Lung CancerKorea, Republic of, United States
-
National Cancer Centre, SingaporeTaiho Pharmaceutical Co., Ltd.Recruiting
-
ETOP IBCSG Partners FoundationJanssen PharmaceuticalsRecruitingNon Small Cell Lung CancerSpain, France, Switzerland, United Kingdom, Singapore, Italy, Netherlands
-
Nalo Therapeutics Inc.RecruitingEGFR Mutation-Related TumorsKorea, Republic of, United States, Taiwan
-
J Ints BioRecruitingEGFR Mutant Advanced Non-small Cell Lung CancerKorea, Republic of, United States, Thailand
-
Instituto Oncológico Dr RosellTurning Point Therapeutics, Inc.Recruiting
-
Memorial Sloan Kettering Cancer CenterAstraZeneca; Guardant Health, Inc.RecruitingMetastatic Non-small Cell Lung CancerUnited States
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingMetastatic Lung Non-Small Cell Carcinoma | Anaplastic Astrocytoma, IDH-Wildtype | Glioblastoma, IDH-Wildtype | Metastatic Malignant Neoplasm in the Central Nervous SystemUnited States
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingEGFR-mutant Non-Small Cell Lung CancerChina
-
ETOP IBCSG Partners FoundationRoche Pharma AGActive, not recruitingEGFRmutant Stage IIIB/C or IV Non-squamous NSCLCSingapore, Spain, Korea, Republic of, Switzerland, Germany
-
Memorial Sloan Kettering Cancer CenterActive, not recruiting
-
Novartis PharmaceuticalsActive, not recruitingEGFR-mutant Non-small Cell Lung CancerTaiwan, Germany, Canada, Italy, Singapore, Hong Kong
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingMetastatic Non-small Cell Lung CancerUnited States
-
Memorial Sloan Kettering Cancer CenterAstraZeneca; Genentech, Inc.CompletedNon-small Cell Lung Cancer | EGFR-mutant Lung CancersUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedLung Cancer | Lung Cancer Metastatic | EGFR Gene MutationUnited States
-
Blueprint Medicines CorporationTerminatedNeoplasms | Respiratory Tract Diseases | Neoplasms by Histologic Type | Lung Diseases | Neoplasms by Site | Adenocarcinoma | Carcinoma | Carcinoma, Non-Small-Cell Lung | Respiratory Tract Neoplasms | Thoracic Neoplasms | Carcinoma, Bronchogenic | Bronchial Neoplasms | Neoplasms, Nerve Tissue | Non Small Cell Lung... and other conditionsUnited States
-
G1 Therapeutics, Inc.CompletedCarcinoma, Non-Small-Cell Lung | Lung Cancer | Non-small Cell Lung CancerUnited States
-
University of SydneyAstraZeneca; Australasian Lung Cancer Trials GroupActive, not recruitingEGFR Mutant Advanced Non Small Cell Lung CancerTaiwan, Australia
-
UNC Lineberger Comprehensive Cancer CenterAstellas Pharma Global Development, Inc.CompletedNon Small Cell Lung CancerUnited States
-
Addario Lung Cancer Medical InstituteWithdrawn
-
The University of Hong KongUnknownNSCLC Stage IV | EGFR Activating Mutation | NSCLC Stage IIIBHong Kong
-
Hellenic Oncology Research GroupUnknownNon Small Cell Lung CancerGreece
-
Memorial Sloan Kettering Cancer CenterIncyte CorporationCompleted
-
Memorial Sloan Kettering Cancer CenterAstellas Pharma US, Inc.CompletedEGFR-Mutant Lung CancerUnited States
-
Finnish Lung Cancer GroupRoche Pharma AGCompleted
-
Guangdong Association of Clinical TrialsGuangdong Provincial People's HospitalCompletedNon Small Cell Lung Cancer | Brain MetastasisChina
-
Sun Yat-sen UniversityUnknownNon-Small Cell Lung CancerChina
-
MedicalLogicKosin University Gospel HospitalUnknownCarcinoma, Non-Small-Cell LungKorea, Republic of